Wird geladen...
Ticagrelor-Induced Prolongation of the QTc Interval
BACKGROUND: Ticagrelor has been accepted as a class I antiplatelet agent in patients undergoing percutaneous coronary angioplasty (PTCA). There have been cases reported on ticagrelor being associated with various cardiac conduction defects. But there is no evidence of QTc prolongation associated wit...
Gespeichert in:
| Veröffentlicht in: | Case Rep Cardiol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Hindawi
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6881594/ https://ncbi.nlm.nih.gov/pubmed/31827937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5984847 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|